TG Therapeutics Inc. Q1 Loss decreases, but misses estimates

(RTTNews) - TG Therapeutics Inc. (TGTX) revealed Loss for first quarter that decreased from last year but missed the Street estimates.

The company's bottom line totaled -$10.707 million, or -$0.07 per share. This compares with -$39.232 million, or -$0.28 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$0.04 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 713.5% to $63.474 million from $7.803 million last year.

TG Therapeutics Inc. earnings at a glance (GAAP) :

-Earnings (Q1): -$10.707 Mln. vs. -$39.232 Mln. last year. -EPS (Q1): -$0.07 vs. -$0.28 last year. -Revenue (Q1): $63.474 Mln vs. $7.803 Mln last year.